Medtronic: Q4 adjusted EPS up 7%
(CercleFinance.com) - Medtronic has posted adjusted Q4 2017-18 EPS that is up 7% at 1.
42 dollar (+15% excluding disposals and FX factors), with revenues that are up 2.9% at 8.1 billion dollars (+6.5% in organic terms).
Over the full year, the medical equipment supplier saw its adjusted EPS rise 4% to 4.77 dollars, for organic sales growth of 4.6% to almost 30 billion dollars, thus reaching the top of its target ranges set at the beginning of the year.
In 2018-19, Medtronic's management - based in Dublin, Ireland - anticipates adjusted EPS of about 10% at between 5.10 dollars and 5.15 dollars, with organic sales growth of between 4% and 4.5%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
42 dollar (+15% excluding disposals and FX factors), with revenues that are up 2.9% at 8.1 billion dollars (+6.5% in organic terms).
Over the full year, the medical equipment supplier saw its adjusted EPS rise 4% to 4.77 dollars, for organic sales growth of 4.6% to almost 30 billion dollars, thus reaching the top of its target ranges set at the beginning of the year.
In 2018-19, Medtronic's management - based in Dublin, Ireland - anticipates adjusted EPS of about 10% at between 5.10 dollars and 5.15 dollars, with organic sales growth of between 4% and 4.5%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.